As of 2026-06-06, the EV/EBITDA ratio of Hanmi Pharm Co Ltd (128940.KS) is
19.00.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 128940.KS's latest enterprise value
is 6,296,115.00 mil KRW. 128940.KS's TTM EBITDA according to its financial statements is
331,335.94 mil KRW. Dividing these 2
quantities gives us the above 128940.KS EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
5.9x - 12.2x |
7.0x |
| Forward P/E multiples |
4.8x - 10.3x |
5.6x |
| Fair Price |
111,278.79 - 316,075.40 |
154,595.07 |
| Upside |
-77.4% - -35.7% |
-68.5% |
491,500.00 KRW
Stock Price
154,595.07 KRW
Fair Price